Natalizumab prevents the accumulation of cortical lesions in relapsing remitting multiple sclerosis: a preliminary report

Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland

(2010) Norman Putzki et al.   EUROPEAN NEUROLOGY

Cortical Lesions and Atrophy Associated With Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis

(2009) Massimiliano Calabrese et al.   ARCHIVES OF NEUROLOGY

Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis

(2009) N. Putzki et al.   EUROPEAN JOURNAL OF NEUROLOGY

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

(2009) Eva Havrdova et al.   LANCET NEUROLOGY

Magnetic resonance evidence of cortical onset of multiple sclerosis

(2009) M Calabrese et al.   Multiple Sclerosis Journal

Cortical lesions in primary progressive multiple sclerosis: A 2-year longitudinal MR study

(2009) M. Calabrese et al.   NEUROLOGY

Extensive cortical inflammation is associated with epilepsy in multiple sclerosis

(2008) M. Calabrese et al.   JOURNAL OF NEUROLOGY

Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study

(2008) M Calabrese et al.   Multiple Sclerosis Journal